ArticleClinical and experimental dermatology2022

Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic.

K Hansel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.